Bajaj Finserv Mutual Fund
All mutual funds

Bajaj Finserv Healthcare Fund - Direct Plan - Growth

Bajaj Finserv Mutual Fund · Sectoral/Thematic · Direct · Growth

NAV · as of 11/09/2026

12.26

1D

-0.21%

1Y

+22.14%

Key stats

Expense ratio
0.88%
AUM
₹376.70 Cr
Launched
27/12/2024
Fund manager
Siddharth Chaudhary; Vinay Bafna; Bharat Hegde
Portfolio turnover
0.41%
Risk
Very High Risk
Min lump-sum
₹500
Min SIP
₹500/mo
Fresh lump-sum
Accepted
Fresh SIP
Accepted

NAV history

Bajaj Finserv Healthcare Fund - Direct Plan - Growth

13/08/2026 to 11/09/2026

O - H - L -

12.4311.9813/08/202611/09/2026
1W+1.06%
1M+1.61%
3M+13.88%
6M+30.73%
1Y+22.14%
MAX+21.65%

Top holdings

39 disclosed
  • 1.

    Divi's Laboratories Ltd

    Healthcare

    9.67%
  • 2.

    Sun Pharmaceuticals Industries Ltd

    Healthcare

    8.87%
  • 3.

    Piramal Pharma Ltd

    Healthcare

    6.60%
  • 4.

    Apollo Hospitals Enterprise Ltd

    Healthcare

    6.50%
  • 5.

    Aurobindo Pharma Ltd

    Healthcare

    6.13%
  • 6.

    Rubicon Research Ltd

    Healthcare

    6.01%
  • 7.

    Torrent Pharmaceuticals Ltd

    Healthcare

    5.48%
  • 8.

    Neuland Laboratories Ltd

    Healthcare

    4.42%
  • 9.

    Emcure Pharmaceuticals Ltd

    Healthcare

    4.37%
  • 10.

    Max Healthcare Institute Ltd Ordinary Shares

    Healthcare

    3.80%
  • 11.

    Fortis Healthcare Ltd

    Healthcare

    3.01%
  • 12.

    Zydus Wellness Ltd

    Consumer Defensive

    2.66%
  • 13.

    Laurus Labs Ltd

    Healthcare

    2.41%
  • 14.

    Ipca Laboratories Ltd

    Healthcare

    2.34%
  • 15.

    Vijaya Diagnostic Centre Ltd

    Healthcare

    2.20%
  • 16.

    Senores Pharmaceuticals Ltd

    Healthcare

    2.11%
  • 17.

    Shaily Engineering Plastics Ltd

    Basic Materials

    2.02%
  • 18.

    Navin Fluorine International Ltd

    Basic Materials

    2.01%
  • 19.

    Dr. Lal PathLabs Ltd

    Healthcare

    1.78%
  • 20.

    Sanofi Consumer Healthcare India Ltd

    Healthcare

    1.70%
  • 21.

    GlaxoSmithKline Pharmaceuticals Ltd

    Healthcare

    1.68%
  • 22.

    Glenmark Pharmaceuticals Ltd

    Healthcare

    1.64%
  • 23.

    Bajaj Money Market Dir Gr

    1.39%
  • 24.

    Dr Reddy's Laboratories Ltd

    Healthcare

    1.37%
  • 25.

    Zydus Lifesciences Ltd

    Healthcare

    1.33%
  • 26.

    Biocon Ltd

    Healthcare

    1.29%
  • 27.

    Clearing Corporation Of India Ltd

    1.15%
  • 28.

    Krishna Institute of Medical Sciences Ltd

    Healthcare

    1.07%
  • 29.

    Medi Assist Healthcare Services Ltd

    Healthcare

    0.96%
  • 30.

    OneSource Specialty Pharma Ltd

    Healthcare

    0.95%
  • 31.

    Jubilant Pharmova Ltd

    Healthcare

    0.87%
  • 32.

    Net Receivables / (Payables)

    0.86%
  • 33.

    Turtlemint Fintech Solutions Ltd

    Financial Services

    0.83%
  • 34.

    Sumitomo Chemical India Ltd Ordinary Shares

    Basic Materials

    0.27%
  • 35.

    MTAR Technologies Ltd

    Industrials

    0.23%
  • 36.

    AstraZeneca Pharma India Ltd

    -
  • 37.

    Abbott India Ltd

    -
  • 38.

    Medplus Health Services Ltd

    -
  • 39.

    Eris Lifesciences Ltd Registered Shs

    -

Sector allocation

  • Healthcare88.58%
  • Basic Materials4.30%
  • Unclassified3.41%
  • Consumer Defensive2.66%
  • Financial Services0.83%
  • Industrials0.23%

Comparable peers

  • Bajaj Finserv Healthcare Growth Direct Plan

    Bajaj Finserv Healthcare (G) · ₹376.70 Cr AUM

    1Y+23.21%
    3Y0.00%
    -
  • SBI Healthcare Opportunities Growth Direct Plan

    SBI Healthcare Opportunities (G) · ₹5.80 K Cr AUM

    1Y+22.13%
    3Y+24.61%
    -
  • Mirae Asset Healthcare Growth Direct Plan

    Mirae Healthcare (G) · ₹3.44 K Cr AUM

    1Y+20.35%
    3Y+23.20%
    -
  • UTI Healthcare Growth Direct Plan

    UTI Healthcare (G) · ₹1.44 K Cr AUM

    1Y+17.28%
    3Y+24.42%
    -
  • HDFC Transportation & Logistics Growth Direct Plan

    HDFC Transportation & Logistics (G) · ₹1.96 K Cr AUM

    1Y+9.79%
    3Y+25.46%
    -

Investment objective

The objective of the Scheme is to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma, healthcare and allied companies.

Scheme details

Scheme code
153157
Fund house
Bajaj Finserv Mutual Fund
Category
Open Ended
Type
Equity Scheme
Sub-category
Sectoral/Thematic
Plan
Direct
Return type
Growth
ISIN (Growth)
INF0QA701AB9
ISIN (Div. Reinvest)
-
Tradable on exchange
No

Kuvera page